Astro-Med (NASDAQ: ALOT) reported Q1 EPS of $0.12. Revenue for the quarter came in at $31.5 million.

“We continued the Company’s strong performance during the first quarter of FY2019 driven by solid revenue growth contributions from both our Test & Measurement (T&M) and Product Identification (PI) segments,” said AstroNova President and CEO Greg Woods.

Business Outlook

“We continue to be positive on our expectations for fiscal 2019 with comparable sales and earnings in the second quarter and improving performance in the second half of the year as we wind down the Transition Services Agreement with Honeywell for our new Aerospace printer line as well as increased revenuecontributions from our new TrojanLabel product lines,” Woods said.

For earnings history and earnings-related data on Astro-Med (ALOT) click here.